Your session is about to expire
← Back to Search
LGBTQ-Affirmative Therapy for Mental Health Issues
Study Summary
This trial will assess if LGBTQ-affirmative CBT and family therapy can reduce depression & anxiety in SGM adults with nonaccepting parents. Investigating how the treatments work to reduce mental health symptoms.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I started a new medication within the last 30 days.You demonstrate moderate levels of parental rejection or reduced degrees of parental acceptance, as assessed by the PARSOS.I am currently receiving mental health treatment more than once a month.I am legally required to undergo treatment.I am over 20 years old.I am currently experiencing significant depression or anxiety.You possess proficiency in the English language.I am currently experiencing significant depression or anxiety.You identify as non-heterosexual.
- Group 1: ABFT-SGM
- Group 2: LGBTQ-affirmative CBT
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What possible risks could be associated with the utilization of LGBTQ-affirmative cognitive behavioral therapy?
"Our in-house experts have assigned a rating of 3 to the safety profile of LGBTQ-affirmative CBT, which is currently undergoing Phase 3 trials with many instances confirming both its efficacy and security."
Are enrollments available for this clinical experiment at the moment?
"The clinicaltrials.gov database implies that this medical study is no longer accepting patients, as it was last updated on March 10th 2023 after its initial posting on 15th of March the same year. Nonetheless, 105 other studies are currently recruiting candidates for their trials."
What are the main aims of this investigation?
"This clinical trial's primary end-point, evaluated at Baseline, Immediate Post-intervention and 5 Month Post Intervention is the transformation in anxiety symptoms. Secondary objectives include a shift in gay/lesbian concealment motivation as assessed with an adapted version of the Lesbian, Gay & Bisexual Identity Scale (LGBIS), alteration in gender minority identity concealment motivation using LGBIS scoring system and change in sexual orientation acceptance concerns measured by the Acceptance Concerns subscale of the LGBIS."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger